EVOXAC ORAL SOLUTION Trademark

Trademark Overview

On Tuesday, August 19, 2025, a trademark application was filed for EVOXAC ORAL SOLUTION with the United States Patent and Trademark Office. The USPTO has given the EVOXAC ORAL SOLUTION trademark a serial number of 99345341. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 3, 2026. This trademark is owned by Cosette Pharmaceuticals, Inc.. The EVOXAC ORAL SOLUTION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Sjogren's syndrome and/or Xerosis
evoxac oral solution

General Information

Serial Number99345341
Word MarkEVOXAC ORAL SOLUTION
Filing DateTuesday, August 19, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 3, 2026

Trademark Statements

NOT AVAILABLEORAL SOLUTION
Goods and ServicesPharmaceutical preparations for the treatment of Sjogren's syndrome and/or Xerosis
Description of MarkThe mark consists of stylized letters Evoxac, in which the "v" continues over the "o" to create the "x" which ends below the "a". Below Evoxac are the words ORAL SOLUTION.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 19, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCosette Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807
Party NameCosette Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Tuesday, August 19, 2025NEW APPLICATION ENTERED
Tuesday, August 19, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, January 7, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 7, 2026NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, January 8, 2026ASSIGNED TO EXAMINER
Thursday, January 8, 2026EXAMINERS AMENDMENT -WRITTEN
Thursday, January 8, 2026EXAMINERS AMENDMENT E-MAILED
Thursday, January 8, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 8, 2026EXAMINER'S AMENDMENT ENTERED
Thursday, January 8, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 28, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 3, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 3, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

solution oral evoxac syndrome xerosis sjogren treatment preparations pharmaceutical